Hepatic safety and biomarker assessments in sorafenib-experienced patients with advanced hepatocellular carcinoma treated with nivolumab in the CheckMate-040 study

Autores: Meyer, T.; Melero Bermejo, Ignacio; Yau, T.; Hsu, C. ; Kudo, M. ; Choo, S. P. ; Trojan, J.; Welling, T. ; Kang, Y. K. ; Yeo, W.; Chopra, A.; Baakili, A.; Cruz, C. D. ; Zhao, H.; Neely, J.; Crocenzi, T.; El-Khoureiry, A.; Sangro Gómez-Acebo, Bruno Carlos